{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:39:21Z","timestamp":1793975961318,"version":"4.8.0"},"reference-count":90,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Hypoparathyroidism is a rare disorder characterized by hypocalcemia and absent or deficient PTH. This report presents a summary of current information about epidemiology, presentation, diagnosis, clinical features, and management and proposes guidelines to help clinicians diagnose, evaluate, and manage this disorder.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants:<\/jats:title>\n                    <jats:p>Participants in the First International Conference on the Management of Hypoparathyroidism represented a worldwide constituency with acknowledged interest and expertise in key basic, translational, and clinical aspects of hypoparathyroidism. Three Workshop Panels were constituted to address questions for presentation and discussion at the Conference held in Florence, Italy, May 7\u20139, 2015. At that time, a series of presentations were made, followed by in-depth discussions in an open forum. Each Workshop Panel also met in closed sessions to formulate the three evidence-based reports that accompany this summary statement. An Expert Panel then considered this information, developed summaries, guidelines, and a research agenda that constitutes this summary statement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Evidence:<\/jats:title>\n                    <jats:p>Preceding the conference, each Workshop Panel conducted an extensive literature search as noted in the individual manuscripts accompanying this report. All presentations were based upon the best peer-reviewed information taking into account the historical and current literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Consensus Process:<\/jats:title>\n                    <jats:p>This report represents the Expert Panel's synthesis of the conference material placed in a context designed to be relevant to clinicians and those engaged in cutting-edge studies of hypoparathyroidism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This document not only provides a summary of our current knowledge but also places recent advances in its management into a context that should enhance future advances in our understanding of hypoparathyroidism.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/jc.2015-3907","type":"journal-article","created":{"date-parts":[[2016,3,4]],"date-time":"2016-03-04T13:00:36Z","timestamp":1457096436000},"page":"2273-2283","source":"Crossref","is-referenced-by-count":362,"title":["Management of Hypoparathyroidism: Summary Statement and Guidelines"],"prefix":"10.1210","volume":"101","author":[{"given":"Maria Luisa","family":"Brandi","sequence":"first","affiliation":[{"name":"Department of Surgery and Translational Medicine (M.L.B.), University of Florence, 50121 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Bilezikian","sequence":"additional","affiliation":[{"name":"Columbia University College of Physicians & Surgeons (J.P.B.), New York, New York 10032"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Shoback","sequence":"additional","affiliation":[{"name":"Endocrine Research Unit (D.S.), San Francisco Department of Veterans Affairs Medical Center, University of California, San Francisco, California 94121"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Bouillon","sequence":"additional","affiliation":[{"name":"Clinic and Laboratory of Experimental Endocrinology (R.B.), Gasthuisberg, KU Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart L.","family":"Clarke","sequence":"additional","affiliation":[{"name":"Mayo Clinic (B.C.), Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Rochester, Minnesota 55905"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh V.","family":"Thakker","sequence":"additional","affiliation":[{"name":"Academic Endocrine Unit (R.V.T.), Radcliffe Department of Medicine, University of Oxford, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford OX3 7LJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliya A.","family":"Khan","sequence":"additional","affiliation":[{"name":"McMaster University Calcium Disorders Clinic (A.A.K.), Hamilton, Canada L8S4L8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"John T.","family":"Potts","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital (J.T.P.), Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071616255247000_B1","doi-asserted-by":"crossref","first-page":"674","DOI":"10.4158\/EP14462.DSC","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology Disease State Clinical Review: postoperative hypoparathyroidism-definitions and management","volume":"21","author":"Stack","year":"2015","journal-title":"Endocr Pract"},{"key":"2020071616255247000_B2","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-15-0628","article-title":"European Society of Endocrinology clinical guideline: treatment of chronic hypoparathyroidism in adults","volume":"173","author":"Bollerslev","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"2020071616255247000_B3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1677\/joe.1.06057","article-title":"Parathyroid hormone: past and present","volume":"187","author":"Potts","year":"2005","journal-title":"J Endocrinol"},{"key":"2020071616255247000_B4","first-page":"130","article-title":"PTH secretion in vivo and in vitro. Regulation by calcium and other secretagogues","volume":"8","author":"Brown","year":"1982","journal-title":"Miner Electrolyte Metab"},{"key":"2020071616255247000_B5","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/jbmr.483","article-title":"Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research","volume":"26","author":"Bilezikian","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2020071616255247000_B6","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1210\/jc.2015-3908","article-title":"Epidemiology and diagnosis of hypoparathyroidism","volume":"101","author":"Clarke","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616255247000_B7","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1210\/jc.2015-3909","article-title":"Presentation of hypoparathyroidism: etiologies and clinical features [published online March 4, 2016]","volume":"101","author":"Shoback","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616255247000_B8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJMcp0803050","article-title":"Clinical practice. Hypoparathyroidism","volume":"359","author":"Shoback","year":"2008","journal-title":"N Engl J Med"},{"key":"2020071616255247000_B9","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJM198405103101904","article-title":"The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects","volume":"310","author":"Cholst","year":"1984","journal-title":"N Engl J Med"},{"key":"2020071616255247000_B10","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1684\/mrh.2011.0289","article-title":"Role of the distal convoluted tubule in renal Mg2+ handling: molecular lessons from inherited hypomagnesemia","volume":"24","author":"Ferr\u00e8","year":"2011","journal-title":"Magnes Res"},{"key":"2020071616255247000_B11","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJM198310133091501","article-title":"Hypoparathyroidism in Wilson's disease","volume":"309","author":"Carpenter","year":"1983","journal-title":"N Engl J Med"},{"key":"2020071616255247000_B12","first-page":"57","article-title":"Wilson's disease presenting with hypokalemia, hypoparathyroidism and renal failure","volume":"60","author":"Ghosh","year":"2012","journal-title":"J Assoc Physicians India"},{"key":"2020071616255247000_B13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4103\/2230-8210.109689","article-title":"Hypoparathyroidism in a case of Wilson's disease: rare association of a rare disorder","volume":"17","author":"Fatima","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"key":"2020071616255247000_B14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0002-9343(72)90086-1","article-title":"Secondary malignant tumors of the parathyroid glands. Report of two cases with associated hypoparathyroidism","volume":"52","author":"Horwitz","year":"1972","journal-title":"Am J Med"},{"key":"2020071616255247000_B15","first-page":"441","article-title":"A case of advanced breast cancer associated with hypocalcemia","volume":"13","author":"Watanabe","year":"1983","journal-title":"Jpn J Clin Oncol"},{"key":"2020071616255247000_B16","first-page":"1063","article-title":"Genetic disorders of calcium homeostasis caused by abnormal regulation of parathyroid hormone secretion or responsiveness","volume-title":"Endocrinology","author":"Thakker","year":"2016"},{"key":"2020071616255247000_B17","doi-asserted-by":"crossref","first-page":"f2213","DOI":"10.1136\/bmj.f2213","article-title":"Investigating hypocalcaemia","volume":"346","author":"Hannan","year":"2013","journal-title":"BMJ"},{"key":"2020071616255247000_B18","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/jbmr.2532","article-title":"A homozygous [Cys25]PTH(1-84) mutation that impairs PTH\/PTHrP receptor activation defines a novel form of hypoparathyroidism","volume":"30","author":"Lee","year":"2015","journal-title":"J Bone Miner Res"},{"key":"2020071616255247000_B19","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/jbmr.2004","article-title":"Prevalence and incidence of hypoparathyroidism in the United States using a large claims database","volume":"28","author":"Powers","year":"2013","journal-title":"J Bone Miner Res"},{"key":"2020071616255247000_B20","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/jbmr.1979","article-title":"Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study","volume":"28","author":"Underbjerg","year":"2013","journal-title":"J Bone Miner Res"},{"key":"2020071616255247000_B21","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/jbmr.2273","article-title":"Postsurgical hypoparathyroidism\u2013risk of fractures, psychiatric diseases, cancer, cataract, and infections","volume":"29","author":"Underbjerg","year":"2014","journal-title":"J Bone Miner Res"},{"key":"2020071616255247000_B22","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/jbmr.2501","article-title":"The epidemiology of nonsurgical hypoparathyroidism in Denmark: a nationwide case finding study","volume":"30","author":"Underbjerg","year":"2015","journal-title":"J Bone Miner Res"},{"key":"2020071616255247000_B23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/archsurg.2007.55","article-title":"Hypoparathyroidism after total thyroidectomy: a prospective study","volume":"143","author":"Asari","year":"2008","journal-title":"Arch Surg"},{"key":"2020071616255247000_B24","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1136\/bmj.39582.589433.BE","article-title":"Diagnosis and management of hypocalcaemia","volume":"336","author":"Cooper","year":"2008","journal-title":"BMJ"},{"key":"2020071616255247000_B25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000342494","article-title":"Genetics and epigenetics of parathyroid hormone resistance","volume":"24","author":"Bastepe","year":"2013","journal-title":"Endocr Dev"},{"key":"2020071616255247000_B26","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/MED.0b013e32835a255c","article-title":"An update on the clinical and molecular characteristics of pseudohypoparathyroidism","volume":"19","author":"Levine","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2020071616255247000_B27","first-page":"1147","article-title":"Pseudohypoparathyroidism, Albright's hereditary osteodystrophy, and progressive osseous heteroplasia: disorders caused by inactivating GNAS mutations","volume-title":"Endocrinology","author":"Bastepe","year":"2016"},{"key":"2020071616255247000_B28","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1210\/jc.2011-1048","article-title":"Clinical review: pseudohypoparathyroidism: diagnosis and treatment","volume":"96","author":"Mantovani","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616255247000_B29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4274\/jcrpe.v2i4.173","article-title":"Vitamin D deficiency rickets mimicking pseudohypoparathyroidism","volume":"2","author":"Ak\u0131n","year":"2010","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"2020071616255247000_B30","first-page":"391","article-title":"Synthetic human parathyroid hormone 1\u201334 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism","volume":"97","author":"Winer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616255247000_B31","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1210\/jc.2014-1414","article-title":"Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Eastell","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616255247000_B32","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.clinbiochem.2012.04.029","article-title":"Acute and chronic regulation of circulating PTH: significance in health and in disease","volume":"45","author":"D'Amour","year":"2012","journal-title":"Clin Biochem"},{"key":"2020071616255247000_B33","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/MED.0b013e3283591502","article-title":"Hypoparathyroidism: from diagnosis to treatment","volume":"19","author":"De Sanctis","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2020071616255247000_B34","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/jc.2013-3863","article-title":"Expression of osteogenic molecules in the caudate nucleus and gray matter and their potential relevance for basal ganglia calcification in hypoparathyroidism","volume":"99","author":"Goswami","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616255247000_B35","doi-asserted-by":"crossref","first-page":"524","DOI":"10.4103\/0972-124X.138755","article-title":"Dental manifestation of primary idiopathic hypoparathyroidism","volume":"18","author":"Srirangarajan","year":"2014","journal-title":"J Indian Soc Periodontol"},{"key":"2020071616255247000_B36","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/B978-0-12-397166-1.00053-9","article-title":"Clinical manifestations of hypoparathyroidism","volume-title":"The Parathyroids","author":"Mannstadt","year":"2015"},{"key":"2020071616255247000_B37","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1359\/jbmr.080803","article-title":"Dynamic and structural properties of the skeleton in hypoparathyroidism","volume":"23","author":"Rubin","year":"2008","journal-title":"J Bone Miner Res"},{"key":"2020071616255247000_B38","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/jbmr.470","article-title":"The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study","volume":"26","author":"Sikjaer","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2020071616255247000_B39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1210\/jc.2012-2984","article-title":"Therapy of hypoparathyroidism with PTH(1-84): a prospective four-year investigation of efficacy and safety","volume":"98","author":"Cusano","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616255247000_B40","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1210\/jc.2003-030470","article-title":"Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects","volume":"88","author":"Chen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616255247000_B41","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bone.2009.09.020","article-title":"Three dimensional cancellous bone structure in hypoparathyroidism","volume":"46","author":"Rubin","year":"2010","journal-title":"Bone"},{"key":"2020071616255247000_B42","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/jbmr.2609","article-title":"Noninvasive assessment of skeletal microstructure and estimated bone strength in hypoparathyroidism","volume":"31","author":"Cusano","year":"2016","journal-title":"J Bone Miner Res"},{"key":"2020071616255247000_B43","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/jbmr.452","article-title":"PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism","volume":"26","author":"Rubin","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2020071616255247000_B44","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-88-470-5376-2_26","article-title":"Bone histomorphometry in hypoparathyroidism","volume-title":"Hypoparathyroidism","author":"Dempster","year":"2015"},{"key":"2020071616255247000_B45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/8756-3282(95)00443-2","article-title":"Bone histomorphometry in hypoparathyroid patients treated with vitamin D","volume":"18","author":"Langdahl","year":"1996","journal-title":"Bone"},{"key":"2020071616255247000_B46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6823-13-1","article-title":"Increased vertebral morphometric fracture in patients with postsurgical hypoparathyroidism despite normal bone mineral density","volume":"13","author":"Mendon\u00e7a","year":"2013","journal-title":"BMC Endocr Disord"},{"key":"2020071616255247000_B47","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1210\/jc.2012-1808","article-title":"Long-term follow-up of patients with hypoparathyroidism","volume":"97","author":"Mitchell","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616255247000_B48","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/eje.0.1460215","article-title":"Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D","volume":"146","author":"Arlt","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"2020071616255247000_B49","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4158\/EP13321.OR","article-title":"Surgeons and patients disagree on the potential consequences from hypoparathyroidism","volume":"20","author":"Cho","year":"2014","journal-title":"Endocr Pract"},{"key":"2020071616255247000_B50","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1530\/EJE-12-0946","article-title":"Neuropsychological dysfunction in idiopathic hypoparathyroidism and its relationship with intracranial calcification and serum total calcium","volume":"168","author":"Aggarwal","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"2020071616255247000_B51","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4158\/EP13328.OR","article-title":"Understanding the burden of illness associated with hypoparathyroidism reported among patients in the paradox study","volume":"20","author":"Hadker","year":"2014","journal-title":"Endocr Pract"},{"key":"2020071616255247000_B52","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1210\/jc.2014-2267","article-title":"PTH(1-84) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy","volume":"99","author":"Cusano","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616255247000_B53","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s00198-014-2677-6","article-title":"Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial","volume":"25","author":"Sikjaer","year":"2014","journal-title":"Osteoporos Int"},{"key":"2020071616255247000_B54","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1210\/jc.2015-1855","article-title":"PTH(1\u201334) for surgical hypoparathyroidism: a prospective, open-label investigation of efficacy and quality of life","volume":"100","author":"Santonati","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616255247000_B55","first-page":"2067","article-title":"Calcium disorders","volume-title":"Principles and Practice of Hospital Medicine","author":"Holt","year":"2012"},{"key":"2020071616255247000_B56","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/9781118453926.ch71","article-title":"Hypocalcemia: definition, etiology, pathogenesis, diagnosis, and management","volume-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","author":"Schafer","year":"2013","edition":"8th ed"},{"key":"2020071616255247000_B57","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0889-8529(18)30171-3","article-title":"Hypocalcemic emergencies","volume":"22","author":"Tohme","year":"1993","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2020071616255247000_B58","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1530\/EJE-11-1094","article-title":"Use of recombinant human parathyroid hormone in hypocalcemic cardiomyopathy","volume":"166","author":"Ballane","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"2020071616255247000_B59","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.bone.2006.02.024","article-title":"Post surgical hypoparathyroidism (HP): treatment with teriparatide (TP)","volume":"38","author":"Castellano","year":"2006","journal-title":"Bone"},{"key":"2020071616255247000_B60","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1530\/EJE-08-0269","article-title":"Successful treatment of vitamin D unresponsive hypoparathyroidism with multipulse subcutaneous infusion of teriparatide","volume":"159","author":"Puig-Domingo","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"2020071616255247000_B61","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1542-4758.2009.00380.x","article-title":"Hypoparathyroidism associated with severe mineral bone disease postrenal transplantation, treated successfully with recombinant PTH","volume":"13","author":"Mahajan","year":"2009","journal-title":"Hemodial Int"},{"key":"2020071616255247000_B62","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/07315724.2001.10719038","article-title":"Absorbability and cost effectiveness in calcium supplementation","volume":"20","author":"Heaney","year":"2001","journal-title":"J Am Coll Nutr"},{"key":"2020071616255247000_B63","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jbmr.5650030303","article-title":"Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate","volume":"3","author":"Harvey","year":"1988","journal-title":"J Bone Miner Res"},{"key":"2020071616255247000_B64","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4158\/EP10241.CR","article-title":"Proton pump inhibitor-induced hypocalcemic seizure in a patient with hypoparathyroidism","volume":"17","author":"Milman","year":"2011","journal-title":"Endocr Pract"},{"key":"2020071616255247000_B65","doi-asserted-by":"crossref","first-page":"219","DOI":"10.7326\/0003-4819-137-3-200208060-00024","article-title":"Tetany secondary to the use of a proton-pump inhibitor","volume":"137","author":"Subbiah","year":"2002","journal-title":"Ann Intern Med"},{"key":"2020071616255247000_B66","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/014556131008900209","article-title":"Proton pump inhibitor suppression of calcium absorption presenting as respiratory distress in a patient with bilateral laryngeal paralysis and hypocalcemia","volume":"89","author":"Zaya","year":"2010","journal-title":"Ear Nose Throat J"},{"key":"2020071616255247000_B67","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(74)91348-8","article-title":"1,25-dihydroxycholecalciferol and 1\u03b1-hydroxycholecalciferol in hypoparathyroidism","volume":"2","author":"Russell","year":"1974","journal-title":"Lancet"},{"key":"2020071616255247000_B68","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJM197510232931702","article-title":"Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 \u03b1,25-dihydroxyvitamin D","volume":"293","author":"Kooh","year":"1975","journal-title":"N Engl J Med"},{"key":"2020071616255247000_B69","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/0026-0495(75)90055-4","article-title":"Effects of 1\u03b1-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 on calcium and phosphorus metabolism in hypoparathyroidism","volume":"24","author":"Neer","year":"1975","journal-title":"Metabolism"},{"key":"2020071616255247000_B70","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1530\/eje.0.1360052","article-title":"Effect of vitamin D treatment in hypoparathyroid patients: a study on calcium, phosphate and magnesium homeostasis","volume":"136","author":"Mortensen","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"2020071616255247000_B71","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/jama.1982.03320310085047","article-title":"Metabolites and analogues of vitamin D. Which for what?","volume":"247","author":"Haussler","year":"1982","journal-title":"JAMA"},{"key":"2020071616255247000_B72","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2265.1994.tb03923.x","article-title":"Hypoparathyroidism\u2013a long-term follow-up experience with 1 \u03b1-vitamin D3 therapy","volume":"40","author":"Halabe","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071616255247000_B73","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2265.2012.04353.x","article-title":"Prevalence and progression of basal ganglia calcification and its pathogenic mechanism in patients with idiopathic hypoparathyroidism","volume":"77","author":"Goswami","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071616255247000_B74","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jocd.2013.08.004","article-title":"Executive summary of the 2013 International Society for Clinical Densitometry Position Development Conference on Bone Densitometry","volume":"16","author":"Schousboe","year":"2013","journal-title":"J Clin Densitom"},{"key":"2020071616255247000_B75","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1210\/jc.2013-1239","article-title":"The effect of PTH(1-84) on quality of life in hypoparathyroidism","volume":"98","author":"Cusano","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616255247000_B76","article-title":"Natpara [package insert]","year":"2015"},{"key":"2020071616255247000_B77","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.1996.03540080053029","article-title":"Synthetic human parathyroid hormone 1\u201334 vs calcitriol and calcium in the treatment of hypoparathyroidism","volume":"276","author":"Winer","year":"1996","journal-title":"JAMA"},{"key":"2020071616255247000_B78","first-page":"3480","article-title":"A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1\u201334 in treatment of hypoparathyroidism","volume":"83","author":"Winer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616255247000_B79","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2002-021736","article-title":"Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1\u201334) versus calcitriol and calcium","volume":"88","author":"Winer","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616255247000_B80","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1210\/jc.2009-2464","article-title":"Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1\u201334 versus calcitriol and calcium","volume":"95","author":"Winer","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616255247000_B81","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jpeds.2014.04.060","article-title":"Effects of pump versus twice-daily injection delivery of synthetic parathyroid hormone 1\u201334 in children with severe congenital hypoparathyroidism","volume":"165","author":"Winer","year":"2014","journal-title":"J Pediatr"},{"key":"2020071616255247000_B82","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.clinthera.2014.04.001","article-title":"Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study","volume":"36","author":"Clarke","year":"2014","journal-title":"Clin Ther"},{"key":"2020071616255247000_B83","doi-asserted-by":"crossref","first-page":"e88237","DOI":"10.1371\/journal.pone.0088237","article-title":"Recombinant human parathyroid hormone related protein 1\u201334 and 1-84 and their roles in osteoporosis treatment","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"2020071616255247000_B84","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/jbmr.1964","article-title":"PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment","volume":"28","author":"Sikjaer","year":"2013","journal-title":"J Bone Miner Res"},{"key":"2020071616255247000_B85","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","article-title":"Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study","volume":"1","author":"Mannstadt","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"2020071616255247000_B86","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/jbmr.2555","article-title":"Transient increased calcium and calcitriol requirements after discontinuation of human synthetic parathyroid hormone 1\u201334 (hPTH 1\u201334) replacement therapy in hypoparathyroidism","volume":"30","author":"Gafni","year":"2015","journal-title":"J Bone Miner Res"},{"key":"2020071616255247000_B87","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/01926230252929882","article-title":"Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1\u201334) for 2 years and relevance to human safety","volume":"30","author":"Vahle","year":"2002","journal-title":"Toxicol Pathol"},{"key":"2020071616255247000_B88","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/01926230601072301","article-title":"Defining a noncarcinogenic dose of recombinant human parathyroid hormone 1-84 in a 2-year study in Fischer 344 rats","volume":"34","author":"Jolette","year":"2006","journal-title":"Toxicol Pathol"},{"key":"2020071616255247000_B89","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/jbmr.1768","article-title":"The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years","volume":"27","author":"Andrews","year":"2012","journal-title":"J Bone Miner Res"},{"key":"2020071616255247000_B90","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1002\/jbmr.1800","article-title":"Safety of osteoanabolic therapy: a decade of experience","volume":"27","author":"Cipriani","year":"2012","journal-title":"J Bone Miner Res"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/101\/6\/2273\/10496580\/jcem2273.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/101\/6\/2273\/10496580\/jcem2273.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T23:14:04Z","timestamp":1594941244000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/101\/6\/2273\/2804718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,1]]},"references-count":90,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2015-3907","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,1]]}}}